Prof Magdalena Plebanski

Related Grants and Projects

• Principal investigator of A New Anti-Diabetes Drug as a Novel Therapy for Ovarian Cancer (funded by National Health and Medical Research Council)
• Participant in A randomised controlled trial of NMDA antagonist, memantine, for the treatment of borderline personality disorder (funded by National Health and Medical Research Council)
• Principal investigator of CD38+ T cells in malaria immuno-suppression (funded by National Health and Medical Research Council)
• Principal investigator of Immune imprinting by nanoparticles and vaccines: new principles and translation into the clinic (funded by National Health and Medical Research Council)
• Principal investigator of Inhibition of allergic airway inflammation by nanoparticles (funded by National Health and Medical Research Council)
• View all 12 related grants and projects